[Human pluripotent stem cells and liver disorders]

Biol Aujourdhui. 2016;210(1):19-26. doi: 10.1051/jbio/2016006. Epub 2016 Jun 10.
[Article in French]


The liver is associated with many diseases including metabolic and cholestatic diseases, cirrhosis as well as chronic and acute hepatitis. However, knowledge about the mechanisms involved in the pathophysiology of these diseases remains limited due to the restricted access to liver biopsies and the lack of cellular models derived from patients. The liver is the main organ responsible for the elimination of xenobiotics and thus hepatocytes have a key role in toxicology and pharmacokinetics. The induced pluripotent stem cells generated from patients with monogenic metabolic disorders, for which the corresponding gene is identified, are relevant in vitro models for the study of the mechanisms involved in generation of pathologies and also for drug screening. Towards this aim, robust protocols for generating liver cells, such as hepatocytes and cholangiocytes, are essential. Our study focused on familial hypercholesterolemia disease modeling, as well as on establishing a protocol for generation of functional cholangiocytes from pluripotent stem cells.

Publication types

  • Review

MeSH terms

  • Cell Differentiation / physiology
  • Hepatocytes / physiology
  • Humans
  • Hyperlipoproteinemia Type II / pathology
  • Induced Pluripotent Stem Cells / physiology*
  • Liver / cytology
  • Liver / pathology
  • Liver Diseases / pathology
  • Liver Diseases / therapy*
  • Models, Biological